2seventy bio Inc. (NASDAQ: TSVT) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT 2SEVENTY BIO INC.

2seventy bio Inc. (NASDAQ: TSVT)
Listen to this Section


$2.72
N/A ( +4.14% ) N/A

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Market Data


Open $2.72
Previous Close $2.72
Volume N/A
Market Cap $140.32M
Day Range $2.61 - $2.73
52 Week Range $2.35 - $6.40
Shares Outstanding 51.59M
Change % +4.14%
Net Change N/A
Insider Ownership -0.02%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2021
Country United States

Insider Ownership Transactions

Total Amount Purchased: -628,857.00

Date Type Amount Purchased Purchaser
2024-08-07 Sale -13.00 Eatwell Victoria
2024-07-03 Sale -108538.00 Snow Jessica
2024-07-03 Sale -586022.00 Baird William D III
2024-07-03 Sale -245864.00 Eatwell Victoria
2024-06-12 Sale -6025.00 Newton Charles W.
2024-06-12 Sale -12050.00 Maus Marcela V.
2024-06-12 Sale -6025.00 Casdin Capital, LLC
2024-06-12 Sale -12050.00 Wei Lin
2024-06-12 Sale -12050.00 Glickman Sarah JS
2024-06-12 Sale -12050.00 Torres Denice

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Mar 20, 2024
defa14a Other 2 Mar 20, 2024
8-k 8K-related 15 Mar 18, 2024
8-k 8K-related 14 Mar 13, 2024
10-k Annual reports 128 Mar 07, 2024
8-k 8K-related 18 Mar 05, 2024
sc Insider transactions 1 Feb 14, 2024
sc Insider transactions 1 Feb 14, 2024
sc Insider transactions 1 Feb 13, 2024
sc Insider transactions 1 Feb 12, 2024

Latest News


× Before browsing our site, please accept our cookies policy